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We report the first case of infection by Neosartorya hiratsukae,
an ascomycete in which the conidial state resembles Aspergil-
lus fumigatus. The fungus caused a brain infection in a Brazil-
ian woman, who died despite itraconazole treatment. Diagnosis
was established by direct microscopic examination, computed
tomographic scan, and magnetic resonance imaging of the
brain, and repeated cultures from the lesions. The in vitro anti-
fungal susceptibility of the isolate is provided.
spergillus fumigatus is the most common filamentous fun-
gus to cause opportunistic infections in humans. Two
close relatives of A. fumigatus, classified in the ascomycetous
genus Neosartorya, have been documented to cause occasional
opportunistic infections (1). These species are N. fischeri and
N. pseudofischeri. The former has been reported on two occa-
sions as causing systemic infection in transplant recipients (2,
3), as well as a mixed pulmonary infection in a patient with
myeloma (4). N. pseudofischeri has been reported to cause dif-
ferent localized and invasive infections (5–9). The conidial
states of these species are morphologically very similar to that
of A. fumigatus.
We describe the first cerebral infection caused by another
species of Neosartorya, N. hiratsukae. This taxon has been
described only in Japan, where it was isolated from air and
from pasteurized aloe juice (10).
Case Report
A 75-year-old Brazilian woman was admitted to the Hos-
pital do Servidor Público Estadual de São Paulo on May 5,
1999, with progressive memory loss, confusion, and involun-
tary movements in the upper right arm after a fall 1 year ear-
lier. She had also developed gait disorder, with short steps and
constant loss of balance that led to a diagnosis of Parkinson’s
disease in a neurology consultation in March 1999; however,
the condition did not respond to the usual treatment. On April
30, a computed tomographic (CT) scan of the brain showed
multiple lesions in both brain hemispheres, after which the
patient was referred to the hospital. Past clinical history
showed an evaluation of productive cough in 1996, with
bloody sputum, night sweats, and intermittent fever; she
underwent bronchoscopy with pathologic examination, which
showed vascular congestion and focal intra-alveolar edema,
but no specific pathogen was identified.
On examination, the patient appeared chronically ill,
mildly pale, disoriented, and confused, although she was able
to follow simple commands. The lungs had decreased sounds
in both lower thirds, with rales. The upper arms moved slowly
and repetitively, with a loss of strength. Tendon reflexes were
normal. The patient underwent surgical exploration, with
drainage of the frontal and occipital lesions. Four samples of a
yellowish, dense liquid were collected. Laboratory examina-
tion did not show neoplastic cells or neutrophils in the liquid.
Direct microscopic examination showed septate hyphae in all
the samples. Cultures were negative for aerobic and anaerobic
bacteria and mycobacteria, and two samples were positive for
a fungus, tentatively identified as Aspergillus sp. The patient
was initially treated for 21 days with ceftriaxone, oxacillin,
and metronidazole without major improvement. When the fun-
gus was isolated, she was treated with amphotericin B and
underwent postdrainage magnetic resonance imaging (MRI) of
the brain, which showed multifocal brain abscesses, including
subtentorial and supratentorial lesions (Figure 1). A chest x-
ray and a CT scan of the thorax showed a small, bilateral pleu-
ral effusion and a left pulmonary cavitary lesion. Left pleural
drainage obtained 80 mL of a clear yellow pleural effusion
with pH 7.5, 19,870 leukocytes/mL and 970 erythrocytes/mL,
with negative cultures for mycobacteria, aerobic and anaerobic
bacteria, and fungi. Refractory hypokalemia developed after
the patient received a total dose of 1 g of amphotericin B,
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Figure 1. Magnetic resonance imaging of the brain obtained after first
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which led to discontinuation of this drug. A course of itracona-
zole (400 mg/day) was initiated.
On the first day of itraconazole therapy, another MRI of
the brain was performed, which showed an increase in the vol-
ume of the abscesses. During the next few days, the patient’s
mental state worsened, and she had another cerebral drainage 8
days later. A yellowish opaque liquid, with a white granular
deposit, was obtained from the frontal and parietal abscesses.
A cerebral fragment was obtained for analysis, which showed
only reactional brain tissue. All cultures were negative for bac-
teria but positive for the same fungus that had been isolated
previously. Her clinical and neurologic status improved, and
she was discharged to a nursing home on July 20, 1999; itra-
conazole (400 mg/day) treatment was continued.
The patient was again admitted to the hospital on August
8, and she stayed for 21 days after being diagnosed with uri-
nary sepsis caused by Escherichia coli. She was successfully
treated with intravenous ceftriaxone. Her neurologic condition
had been stable since her previous hospital discharge. She was
last seen at the outpatient clinic on September 29, with an
unchanged neurologic condition. During the hospital stay,
another MRI of the brain showed a decrease in the size of all
lesions, which was interpreted as a good response to the itra-
conazole therapy. Because of the difficulties of maintaining
home care, she was admitted to another nursing hospital. Her
clinical state deteriorated, and she died in November 1999
from multiple organ failure. Clinical information on this last
hospital admission is very limited, and a postmortem examina-
tion was not performed.
Cultures obtained on the two occasions yielded molds with
identical morphologic features, and one isolate was referred to
the Medical School of Rovira i Virgili University in Reus, Tar-
ragona, Spain, for identification purposes.
The isolate was subcultured on Czapek agar and malt
extract agar (MEA), and incubated at approximately 25°C in
the dark. After 14 days, the colonies on Czapek agar were very
restricted (12 mm–14 mm in diameter), velvety, irregularly
folded, umbonate, and white to yellowish white, with a pale
yellow reverse. Sporulation was absent. On MEA, the colonies
developed rapidly, attaining a diameter of 40 mm–46 mm in 14
days. They were velvety, radially folded, white to greenish
white, with a pale yellow reverse. Ascomata and conidial
heads developed throughout the culture. The fungus grew
restrictedly at 45°C. 
The microscopic features of ascomata and conidial heads
were examined from wet mounts prepared in lactic acid under
light microscopy. Ascomata were non-ostiolate, superficial,
white to light cream colored, globose or subglobose, measur-
ing 120 µm–600 µm in diameter, and covered with a white
aerial mycelium. The peridium was thin and membranous. The
asci were eight-spored, more or less globose, and measured
11µm–15 µm in diameter. The ascospores were hyaline, one-
celled, and lenticular, with two closely oppressed equatorial
crests. They measured 6 µm–7.5 µm x 4 µm–5 µm, including
the crests, and their convex walls showed a fine reticulate
ornamentation. Numerous conidiophores of an Aspergillus sp.
were intermixed with the ascomata. The conidiophores con-
sisted of green to bluish green, uniseriate, short columnar
conidial heads over hyaline to light green, smooth and thick-
walled stipes, which measured 100 µm–170 µm x 3 µm–4 µm.
The conidia were pale greenish, globose or subglobose, 2 µm–
2.5 µm in diameter and with smooth or delicately roughened
walls.
On the basis of the above characteristics, and especially
taking into account the ascospore ornamentation observed
under scanning electron microscopy (Figure 2), we identified
the isolate as N. hiratsukae (10,11). The isolate was morpho-
logically compared with the type strain of N. hiratsukae (NHL
3008) and was proven to be the same species (Figure 2A,B). In
addition, N. hiratsukae is the only species of Neosartorya with
reticulated ascospores that grow restrictedly on Czapek agar, a
characteristic also shown in the case isolate. N. pseudofischeri,
the most common Neosartorya species involved in human
infections, is easily distinguished because its ascospore walls
are ornamented with raised flaps of tissue resembling triangu-
lar projections or long ridge lines (Figure 2C). Living cultures
of the case strain are deposited in the Centraalbureau voor
Schimmelcultures, the Netherlands (CBS 109356) and in the
Institute of Hygiene and Epidemiology, Belgium (IHEM
18438).
The case isolate was tested to determine its susceptibility
to five antifungal drugs. Tests were carried out by a microdilu-
tion method described previously (12) and adapted from the
reference method for molds recommended by the National
Committee for Clinical Laboratory Standards (13), with RPMI
1640 medium buffered to pH 7.0 with 0.165 M morpho-
linepropanesulfonic acid, an inoculum of 9.1 x 105 CFU/mL,
an incubation temperature of 30°C, a second-day reading (48
h), and an additive drug-dilution procedure. MICs and mini-
mum fungicidal concentrations (MFC) were as follows:
Figure 2. Ascospores of  Neosartorya hiratsukae, CBS 109356 (A) and
NHL 3008 (B), and of N. pseudofischeri, NRRL 3496 (C), under scan-
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amphotericin B 1 and >16 µg/mL, flucytosine 64 and >64 µg/
mL, itraconazole 0.25 and 0.25 µg/mL, voriconazole 0.25 and
0.5 µg/mL, and UR-9825 0.06 and 0.5 µg/mL, respectively.
Results demonstrated good activity of the four-azole deriva-
tives tested. UR-9825, a novel triazole not yet licensed,
showed the lowest MIC. MFCs of amphotericin B and flucy-
tosine were very high, indicating the ineffectiveness of these
drugs. These data correlate with our clinical results since a
total dose of 1 g of amphotericin B was unable to reduce the
brain abscesses, while the patient responded well to itracona-
zole at daily doses of 400 mg.
This case report is important because such clinical isolates
of Neosartorya spp. that produce white colonies and do not
become green, like colonies of A. fumigatus, are often dis-
carded as contaminants. Therefore, the real incidence of
aspergillosis caused by Neosartorya species could be under-
reported. Many Neosartorya species, other than N. fischeri or
N. pseudofischeri, are thermotolerant and can grow at temper-
atures above 37°C, showing their inherent ability to invade the
brain.
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